Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
21.10
+0.92 (4.56%)
At close: May 29, 2026, 4:00 PM EDT
21.50
+0.40 (1.90%)
After-hours: May 29, 2026, 7:32 PM EDT
Prenetics Global Revenue
In the year 2025, Prenetics Global had annual revenue of $92.39M with 479.76% growth. Prenetics Global had revenue of $36.56M in the quarter ending December 31, 2025, with 457.03% growth.
Revenue (ttm)
$92.39M
Revenue Growth
+296.55%
P/S Ratio
3.84
Revenue / Employee
$942,755
Employees
98
Market Cap
355.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 92.39M | 76.45M | 479.76% |
| Dec 31, 2024 | 15.94M | 9.78M | 158.91% |
| Dec 31, 2023 | 6.16M | -7.01M | -53.24% |
| Dec 31, 2022 | 13.16M | 631.30K | 5.04% |
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
| Dec 31, 2020 | 65.18M | 55.95M | 605.93% |
| Dec 31, 2019 | 9.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 829.00M |
| OPKO Health | 581.12M |
| CareDx | 412.82M |
| Castle Biosciences | 339.92M |
| Fulgent Genetics | 320.35M |
| FONAR | 105.34M |
| Biodesix | 96.10M |
| Burning Rock Biotech | 77.14M |
PRE News
- 8 days ago - MEXC SPACEX(PRE) Launchpad Subscriptions Surpass $56 million, with the Offering Oversubscribed by Up to 15.5x - GlobeNewsWire
- 10 days ago - Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership - GlobeNewsWire
- 16 days ago - Prenetics Global Q1 Earnings Call Highlights - MarketBeat
- 16 days ago - Prenetics Global Earnings Call Transcript: Q1 2026 - Transcripts
- 16 days ago - Prenetics Global Earnings release: Q1 2026 - Filings
- 16 days ago - Prenetics Global Slides: Q1 2026 - Filings
- 16 days ago - Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 - GlobeNewsWire
- 16 days ago - Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M - GlobeNewsWire